Erratum to: Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant
Ann Hematol. 2016 Jan;95(2):363.
doi: 10.1007/s00277-015-2563-0.
1 Department of Hematology-Oncology, Chonnam National, University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea.
2 Department of Hematology-Oncology, Chonnam National, University Hwasun Hospital, 322 Seoyangro, Hwasun, Jeollanamdo, 519-763, Republic of Korea. [email protected].
3 Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, Republic of Korea.
4 Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Canada.
5 Division of Hematology-Oncology, Samsung Medical Center, Seoul, South Korea.
6 Department of Hematology, Cancer Research Institute, Seoul St. Mary's Hospital, Colllege of Medicine, The Catholic University of Korea, Seoul, South Korea.
7 Department of Hematology-Oncology, Kyungpook National University Hospital, Daegu, South Korea.
8 Department of Hematology-Oncology, Soon ChunHyangUniversity Hospital, Seoul, South Korea.
9 Department of Hematology-Oncology, Dong-A University College of Medicine, Busan, South Korea.